Insulet | PODD - Net Income


Insulet reported $141.1M in Net Income for its fiscal quarter ending in September of 2026.





Net Income Change Date
Abbott USD 920M 8M Sep/2026
Align Technology USD 135.04M 26.75M Sep/2026
AtriCure USD 4.06M 4.89M Sep/2026
Baxter International USD 294M 168M Sep/2026
Becton, Dickinson and Co. USD 696M 319M Sep/2026
Boston Scientific USD 582M 325M Sep/2026
Cardinal Health USD 554M 156M Sep/2026
Cooper Companies USD 432.8M 510.7M Jun/2026
Dexcom USD 249.1M 49.6M Jun/2026
Edwards Lifesciences USD 307.5M 65.6M Sep/2026
Eli Lilly USD 7.1B 301M Jun/2026
Globus Medical USD 141.17M 10.4M Sep/2026
ICU Medical USD 19.09M 11.04M Jun/2026
Inogen USD -5.96M 373K Sep/2024
Insulet USD 141.1M 46.1M Sep/2026
Integra LifeSciences USD 14.85M 10.37M Sep/2026
J&J USD 210M 5.32B Sep/2026
Medtronic USD 1.47B 227M Jun/2026
Merit Medical Systems USD 38.8M 2.19M Jun/2026
Roche Holding CHF 6.87B 1.4B Jun/2026
Solventum Corp USD -12M 104M Sep/2026
Stryker USD 1.28B 531M Jun/2026
Tandem Diabetes Care USD -7.08M 14.08M Sep/2026
Teleflex USD 927.43M 827.73M Sep/2026
West Pharmaceutical Services USD 214M 60M Sep/2026
Zimmer Biomet Holdings USD 191.6M 6.7M Sep/2026